Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1.
作者信息
Mykytyn Anna Z, Rosu Miruna E, Kok Adinda, Rissmann Melanie, van Amerongen Geert, Geurtsvankessel Corine, de Vries Rory D, Munnink Bas B Oude, Smith Derek J, Koopmans Marion P G, Lamers Mart M, Fouchier Ron A M, Haagmans Bart L
机构信息
Viroscience Department, Erasmus Medical Center, Rotterdam 3015CN, Netherlands.
Viroclinics Biosciences BV, Viroclinics Xplore, Schaijk, Netherlands.
出版信息
Lancet Microbe. 2023 May;4(5):e294-e295. doi: 10.1016/S2666-5247(22)00384-6. Epub 2023 Jan 16.
Abstract
摘要
相似文献
1
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变种BM.1.1.1、BQ.1.1和XBB.1的抗原图谱分析
Lancet Microbe. 2023 May;4(5):e294-e295. doi: 10.1016/S2666-5247(22)00384-6. Epub 2023 Jan 16.
2
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB.奥密克戎亚变种包括 BQ.1.1 和 XBB. 导致的 SARS-CoV-2 抗体逃逸的更新图谱
Cell Rep Med. 2023 Apr 18;4(4):100991. doi: 10.1016/j.xcrm.2023.100991. Epub 2023 Mar 21.
3
Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2.新型冠状病毒奥密克戎亚变体XBB.1.5、BQ.1、BQ.1.1、BF.7和BA.2.75.2的抗原特性
Signal Transduct Target Ther. 2023 Mar 15;8(1):125. doi: 10.1038/s41392-023-01391-x.
4
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.令人担忧的 SARS-CoV-2 BQ 和 XBB 亚型不断出现的抗体逃逸特性。
Cell. 2023 Jan 19;186(2):279-286.e8. doi: 10.1016/j.cell.2022.12.018. Epub 2022 Dec 14.
5
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.SARS-CoV-2 变异株的基因组监测：奥密克戎谱系的传播-美国，2022 年 1 月-2023 年 5 月。
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):651-656. doi: 10.15585/mmwr.mm7224a2.
6
Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.在接受 Evusheld 治疗的个体中，对 SARS-CoV-2 奥密克戎 BA.2、BA.2.75、BA.2.76、BA.5、BF.7、BQ.1.1 和 XBB.1.5 的血清中和作用。
J Med Virol. 2023 Jul;95(7):e28932. doi: 10.1002/jmv.28932.
7
Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变种BF.7、XBB.1.5、BQ.1和BQ.1.1带来的全球威胁：值得关注的变种？
Hum Cell. 2023 May;36(3):1218-1221. doi: 10.1007/s13577-023-00903-9. Epub 2023 Mar 31.
8
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model.在仓鼠模型中评估索特罗维单抗对 BQ.1.1 和 XBB.1 奥密克戎亚谱系的活性。
Antiviral Res. 2023 Jul;215:105638. doi: 10.1016/j.antiviral.2023.105638. Epub 2023 May 18.
9
Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.2022年10月至11月意大利SARS-CoV-2变体的废水监测：XBB.1、BA.2.75的检测以及BQ.1谱系的快速传播
Sci Total Environ. 2023 May 15;873:162339. doi: 10.1016/j.scitotenv.2023.162339. Epub 2023 Feb 21.
10
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy.意大利不同疫苗接种方案接种 6 个月后对 SARS-CoV-2 奥密克戎亚系的免疫反应评估。
Acta Trop. 2023 Dec;248:107042. doi: 10.1016/j.actatropica.2023.107042. Epub 2023 Oct 18.
引用本文的文献
1
Cross-neutralization of human sera with diverse SARS-CoV-2 omicron exposure histories, 2022-2024: Evidence of immune heterogeneity.2022 - 2024年不同SARS-CoV-2奥密克戎暴露史人群血清的交叉中和作用：免疫异质性证据
One Health. 2025 Jul 17;21:101145. doi: 10.1016/j.onehlt.2025.101145. eCollection 2025 Dec.
2
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US.美国康涅狄格州2022年新冠病毒奥密克戎谱系替代动态的综合分析
Viruses. 2025 Jul 21;17(7):1020. doi: 10.3390/v17071020.
3
Back-projection improves inference from sparsely sampled genomic surveillance data.反向投影改善了从稀疏采样的基因组监测数据中进行的推断。
bioRxiv. 2025 Jul 1:2025.06.29.662219. doi: 10.1101/2025.06.29.662219.
4
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study.荷兰按CD4 + T细胞计数分层的HIV感染者中COVID-19疫苗免疫原性的纵向评估：一项为期两年的随访研究。
PLoS One. 2025 May 19;20(5):e0323792. doi: 10.1371/journal.pone.0323792. eCollection 2025.
5
Genome data artifacts and functional studies of deletion repair in the BA.1 SARS-CoV-2 spike protein.BA.1 型严重急性呼吸综合征冠状病毒 2 刺突蛋白的基因组数据伪像及缺失修复的功能研究
Virus Evol. 2025 Mar 11;11(1):veaf015. doi: 10.1093/ve/veaf015. eCollection 2025.
6
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion.基于刺突抗原性的严重急性呼吸综合征冠状病毒2血清分型及其对宿主免疫逃逸的影响
EBioMedicine. 2025 Apr;114:105634. doi: 10.1016/j.ebiom.2025.105634. Epub 2025 Mar 12.
7
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.喀麦隆个体感染新型冠状病毒后针对刺突蛋白的纵向体液免疫
Virology. 2025 Apr;605:110467. doi: 10.1016/j.virol.2025.110467. Epub 2025 Feb 25.
8
Nonhuman primate antigenic cartography of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的非人灵长类动物抗原图谱
Cell Rep. 2025 Jan 28;44(1):115140. doi: 10.1016/j.celrep.2024.115140. Epub 2025 Jan 3.
9
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials.三价重组蛋白疫苗诱导对XBB谱系和JN.1亚变体的交叉中和作用：临床前和1期临床试验
Nat Commun. 2024 Dec 30;15(1):10778. doi: 10.1038/s41467-024-55087-z.
10
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data.血清动力学：使用血清学数据进行流行病学推断方法的入门介绍与综合综述
Epidemics. 2024 Dec;49:100806. doi: 10.1016/j.epidem.2024.100806. Epub 2024 Nov 30.
本文引用的文献
1
Mapping SARS-CoV-2 antigenic relationships and serological responses.绘制 SARS-CoV-2 抗原关系和血清学反应图。
Science. 2023 Oct 6;382(6666):eadj0070. doi: 10.1126/science.adj0070.
2
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.原始mRNA疫苗或BA.5二价加强针 对SARS-CoV-2奥密克戎BA.2.75.2、BQ.1.1和XBB.1的中和作用较低。
Nat Med. 2023 Feb;29(2):344-347. doi: 10.1038/s41591-022-02162-x. Epub 2022 Dec 6.
3
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history.抗原绘图分析来自临床特征明确的人类血清样本，显示出基于感染和接种疫苗史的 SARS-CoV-2 中和差异。
Cell Host Microbe. 2022 Dec 14;30(12):1745-1758.e7. doi: 10.1016/j.chom.2022.10.012. Epub 2022 Oct 21.
4
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.针对新冠病毒奥密克戎亚谱系的印记抗体反应。
Science. 2022 Nov 11;378(6620):619-627. doi: 10.1126/science.adc9127. Epub 2022 Oct 20.
5
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron.利用针对已测序的受关注 SARS-CoV-2 变异株感染的血清进行抗原绘图揭示了奥密克戎的抗原差异。
Immunity. 2022 Sep 13;55(9):1725-1731.e4. doi: 10.1016/j.immuni.2022.07.018. Epub 2022 Aug 5.
6
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct.SARS-CoV-2 抗原图谱显示，奥密克戎 BA.1 和 BA.2 具有不同的抗原性。
Sci Immunol. 2022 Sep 23;7(75):eabq4450. doi: 10.1126/sciimmunol.abq4450.
Zotero 插件